Bispecific antibodies specific for PD1 and TIM3
US-12391757-B2 · Aug 19, 2025 · US
This page is not indexed by search engines while we improve data quality.
Perro Mario patents
Perro Mario is listed as an inventor on 11 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Perro Mario |
| Total patents | 11 |
| First publication | Apr 27, 2017 |
| Latest publication | Aug 19, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination therapy of anti-cd20/anti-cd3 bispecific antibodies and 4-1bb (cd137) agonists
US-2024109976-A1 · Apr 4, 2024 · US
Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding molecules
US-2024092856-A1 · Mar 21, 2024 · US
Combination therapy employing a pd1-lag3 bispecific antibody and a cd20 t cell bispecific antibody
US-2024002546-A1 · Jan 4, 2024 · US
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists
US-11718680-B2 · Aug 8, 2023 · US
Bispecific antibodies specific for pd1 and tim3
US-2022259314-A1 · Aug 18, 2022 · US
Bispecific antibodies specific for PD1 and TIM3
US-11130810-B2 · Sep 28, 2021 · US
Combination therapy of anti-cd20/anti-cd3 bispecific antibodies and 4-1bb (cd137) agonists
US-2020325238-A1 · Oct 15, 2020 · US
Bispecific antibodies specific for pd1 and tim3
US-2019322748-A1 · Oct 24, 2019 · US
Bispecific antibodies specific for PD1 and TIM3
US-10287352-B2 · May 14, 2019 · US
Recent patents
Latest publications not already listed above.
Bispecific antibodies specific for pd1 and tim3
US-2017114135-A1 · Apr 27, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 11 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 11 |
| C07K2317/31 | 11 |
| C07K16/2818 | 11 |
| C07K16/468 | 10 |
| A61K2039/505 | 10 |